Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response
Cited by 53
Related Papers
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
|Molecular Cancer|2021|2.2k
A blueprint for tumor-infiltrating B cells across human cancers
|Science|2024|199
A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance
|Theranostics|2020|169
Melatonin attenuates acute kidney ischemia/reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway
|Bioscience Reports|2018|133
Multipoint targeting of the PI3K/mTOR pathway in mesothelioma
|British Journal of Cancer|2014|93